{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:14:22Z","timestamp":1769184862043,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11739-023-03372-y","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T16:02:23Z","timestamp":1689868943000},"page":"1919-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ceftriaxone 1\u00a0g versus 2\u00a0g per day, for the treatment of community-acquired pneumonia: a retrospective cohort study"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-8950","authenticated-orcid":false,"given":"Dmitri","family":"Guz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Buchrits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Goshen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomer","family":"Avni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"issue":"3","key":"3372_CR1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mcna.2018.12.008","volume":"103","author":"CW Lanks","year":"2019","unstructured":"Lanks CW, Musani AI, Hsia DW (2019) Community-acquired pneumonia and hospital-acquired pneumonia. Med Clin North Am 103(3):487\u2013501","journal-title":"Med Clin North Am"},{"issue":"3","key":"3372_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.chest.2018.05.021","volume":"154","author":"GW Waterer","year":"2018","unstructured":"Waterer GW, Self WH, Courtney DM, Grijalva CG, Balk RA, Girard TD et al (2018) In-hospital deaths among adults with community-acquired pneumonia. Chest 154(3):628\u2013635","journal-title":"Chest"},{"issue":"7","key":"3372_CR3","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K et al (2019) Diagnosis and Treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America. Am J Respir Crit Care Med 200(7):e45-67","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3372_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/14787210.2019.1627872","volume":"17","author":"JP Telles","year":"2019","unstructured":"Telles JP, Cieslinski J, Gasparetto J, Tuon FF (2019) Efficacy of ceftriaxone 1 g daily versus 2 g daily for the treatment of community-acquired pneumonia: a systematic review with meta-analysis. Expert Rev Anti Infect Ther 17(7):501\u2013510","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"3372_CR5","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1186\/s12879-019-4552-8","volume":"19","author":"S Hasegawa","year":"2019","unstructured":"Hasegawa S, Sada R, Yaegashi M, Morimoto K, Mori T, Abe M et al (2019) 1g versus 2 g daily intravenous ceftriaxone in the treatment of community onset pneumonia \u2013 a propensity score analysis of data from a Japanese multicenter registry. BMC Infect Dis 19(1):1079","journal-title":"BMC Infect Dis"},{"key":"3372_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijid.2019.06.013","volume":"85","author":"A Kenig","year":"2019","unstructured":"Kenig A, Regev-Yochay G, Khakshoor S, Cohen-Poradosu R, Bishara J, Glikman D et al (2019) Hospital-onset adult invasive pneumococcal disease in Israel: sicker patients, different pathogens. Int J Infect Dis 85:195\u2013202","journal-title":"Int J Infect Dis"},{"issue":"5","key":"3372_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI et al (2003) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58(5):377\u2013382","journal-title":"Thorax"},{"issue":"1","key":"3372_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17(1):204","journal-title":"Crit Care"},{"issue":"77","key":"3372_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","volume":"20","author":"SI Blot","year":"2014","unstructured":"Blot SI, Pea F, Lipman J (2014) The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2013concepts appraised by the example of antimicrobial agents. Adv Drug Deliv Rev 20(77):3\u201311","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"3372_CR10","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jcrc.2009.12.004","volume":"25","author":"A Artero","year":"2010","unstructured":"Artero A, Zaragoza R, Camarena JJ, Sancho S, Gonz\u00e1lez R, Nogueira JM (2010) Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care 25(2):276\u2013281","journal-title":"J Crit Care"},{"issue":"2","key":"3372_CR11","first-page":"66","volume":"23","author":"P SanzCaraba\u00f1a","year":"2006","unstructured":"SanzCaraba\u00f1a P, Ramos Mart\u00ednez A, Asensio Vegas A, Garc\u00eda Navarro MJ, Linares RM (2006) Mortality and prognostic factors in patients admitted with community-acquired bacteremia. An Med Interna 23(2):66\u201372","journal-title":"An Med Interna"},{"issue":"3","key":"3372_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bcp.12636","volume":"80","author":"M Schleibinger","year":"2015","unstructured":"Schleibinger M, Steinbach CL, T\u00f6pper C, Kratzer A, Liebchen U, Kees F et al (2015) Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients. Br J Clin Pharmacol 80(3):525\u2013533","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3372_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","volume":"27","author":"DM Richards","year":"1984","unstructured":"Richards DM, Heel RC, Brogden RN, Speight TM, Avery GS (1984) Ceftriaxone: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 27(6):469\u2013527","journal-title":"Drugs"},{"issue":"4","key":"3372_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0025-7125(16)30034-7","volume":"79","author":"NC Klein","year":"1995","unstructured":"Klein NC, Cunha BA (1995) Third-generation cephalosporins. Med Clin North Am 79(4):705\u2013719","journal-title":"Med Clin North Am"},{"issue":"9","key":"3372_CR15","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1128\/JCM.00893-06","volume":"44","author":"A Klekner","year":"2006","unstructured":"Klekner A, Bagyi K, Bognar L, Gaspar A, Andrasi M, Szabo J (2006) Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia. J Clin Microbiol 44(9):3418\u20133421","journal-title":"J Clin Microbiol"},{"issue":"12","key":"3372_CR16","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.36.12.2804","volume":"36","author":"C Martin","year":"1992","unstructured":"Martin C, Ragni J, Lokiec F, Guillen JC, Auge A, Pecking M et al (1992) Pharmacokinetics and tissue penetration of a single dose of ceftriaxone (1000 milligrams intravenously) for antibiotic prophylaxis in thoracic surgery. Antimicrob Agents Chemother 36(12):2804\u20132807","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3372_CR17","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","volume":"86","author":"S Doron","year":"2011","unstructured":"Doron S, Davidson LE (2011) Antimicrobial stewardship. Mayo Clin Proc 86(11):1113\u20131123","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"3372_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/jac\/48.4.463","volume":"48","author":"SJ Dancer","year":"2001","unstructured":"Dancer SJ (2001) The problem with cephalosporins. J Antimicrob Chemother 48(4):463\u2013478","journal-title":"J Antimicrob Chemother"},{"key":"3372_CR19","unstructured":"LiverTox: clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): national institute of diabetes and digestive and kidney diseases; 2012 [cited 2022 Apr 24]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-023-03372-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-023-03372-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T18:24:47Z","timestamp":1696098287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-023-03372-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["3372"],"URL":"https:\/\/doi.org\/10.1007\/s11739-023-03372-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was a retrospective analysis and data were derived from patient charts. Therefore, informed consent was\nnot required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was approved by the institutional research ethics committee of the Rabin Medical Center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}}]}}